Global Patent Index - EP 1071775 A2

EP 1071775 A2 2001-01-31 - HUMAN NUCLEIC ACID SEQUENCES OF ENDOMETRIUM TUMOUR TISSUE

Title (en)

HUMAN NUCLEIC ACID SEQUENCES OF ENDOMETRIUM TUMOUR TISSUE

Title (de)

MENSCHLICHE NUKLEINSÄURESEQUENZEN AUS ENDOMETRIUMTUMORGEWEBE

Title (fr)

SEQUENCES D'ACIDE NUCLEIQUE HUMAINES PROVENANT D'UNE TUMEUR DE L'ENDOMETRE

Publication

EP 1071775 A2 (DE)

Application

EP 99923403 A

Priority

  • DE 9901174 W
  • DE 19817948 A

Abstract (en)

[origin: DE19817948A1] 141 specified nucleic acid (cDNA) sequences (A), fully defined in the specification, that are highly expressed in uterine tumor tissue, are new. Independent claims are also included for the following: (a) a subset (A') of 126 (A) that encode at least part of a gene product, the allelic variants of (A') and the complements of (A') or their allelic variants; (b) bacterial or phage artificial chromosomes and cosmid clones containing functional genes, or the chromosome region containing them, corresponding to (A') for use as gene transfer vehicles; (c) nucleic acid sequences containing part of (A) sufficiently long to hybridize with (A); (d) expression cassette (EC) comprising (A), or their fragments, plus control and regulatory sequences; (e) DNA fragments containing a gene isolated using (A); (f) host cells containing (A) as a heterologous component; (g) recombinant production of polypeptides (B), or their fragments, by culturing cells of (f); (h) antibody (Ab) directed against (B), or its fragments, encoded by (A); (j) 386 partial polypeptide sequences, all reproduced, and sequences having at least 80% homology with them; (k) pharmaceutical composition containing at least one of these partial sequences; and (l) genomic genes, their promoters, enhancers, silencers, exon or intron structures, or splice variants obtained using (A).

IPC 1-7 (main, further and additional classification)

C12N 15/12; A61K 38/17; A61K 48/00; C07K 14/47; C07K 16/18; C12N 5/10; C12N 15/10; C12N 15/62; C12N 15/70; C12N 15/79; C12Q 1/68; G01N 33/68

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61K 48/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 5/10 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01)

CPC (invention and additional information)

C07K 14/47 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C07K 2319/00 (2013.01)

Citation (search report)

See references of WO 9954461A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI NL PT SE

EPO simple patent family

DE 19817948 A1 19991021; EP 1071775 A2 20010131; JP 2002532055 A 20021002; US 6620923 B1 20030916; WO 9954461 A2 19991028; WO 9954461 A3 20000706

INPADOC legal status


2005-05-11 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20041103

2004-05-26 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: HINZMANN, BERND, DR.

2004-05-26 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: ROSENTHAL, ANDRE, PROF.

2004-05-26 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: SPECHT, THOMAS, DR.

2004-05-26 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: PILARSKY, CHRISTIAN, DR.

2002-02-06 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: METAGEN PHARMACEUTICALS GMBH

2001-01-31 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001019

2001-01-31 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI NL PT SE